Denna sida på svenska

Gustav Stålhammar

Associated

Visiting address : St. Erik Eye Hospital ; Polhemsgatan 50, 11282 Stockholm, Sweden
Postal address : Department of Clinical Neuroscience (CNS), K8, Eye and vision Seregard/Kvanta, St. Erik Eye Hospital ; Polhemsgatan 50, 11282 Stockholm, Sweden
Delivery address : St. Erik Eye Hospital ; Polhemsgatan 50, 11282 Stockholm, Sweden

About me

M.D. Ph.D. FEBO

St. Erik Eye Hospital

Department of Clinical Neuroscience, Karolinska Institutet

Stockholm, Sweden

Education

2018-2019. Clinical and Research Fellowship, Ocular Oncology and Pathology, Emory Eye Center, Emory University Hospital, Atlanta, USA

2018. Fellow of the European Board of Ophthalmology, FEBO. Board certified ophthalmologist.

2013-2017. Ph.D. Deptartment of Oncology and Pathology, Karolinska Institutet, Sweden

2005-2011. University Medical Degree, M.D. Uppsala University, Sweden

2007. Pathology, Université Catholique de Lille, France

Research description

  • Ocular oncology and pathology

Teaching portfolio

  • Ophthalmology, Karolinska Institutet
  • Mentorship for medical students, Karolinska Institutet
  • Clinical courses, St Erik Eye Hospital
  • Human anatomy, Uppsala University

Academic honours, awards and prizes

  • Swedish Society of Pathology Dissertation of the Year 2017: Link
  • Susan G. Komen AACR Scholar in training award, San Antonio Breast Cancer Symposium 2015
  • Research grants, St. Erik Research Foundation, Swedish Eye Foundation, Karolinska Institutet and unrestricted departmental grant for retinoblastoma research from Research to Prevent Blindness, Emory University School of Medicine
  • Linck and Wallmark scholarships, Uppsala University 2010
  • Alreik and Erasmus scholarsips, Uppsala University 2007

Documents

Publications

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
Stålhammar G, See Tro, Phillips S, Seregard S, Grossniklaus He
Translational vision science & technology 2019;8(3):11-

Expression of immune checkpoint receptors Indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
Stålhammar G, Seregard S, Grossniklaus He
Cancer medicine 2019;():-

Neurothekeoma of the eye, conjunctiva, and periorbital adnexa: A report of two cases and brief review
See Tro, Stålhammar G, Grossniklaus He
Survey of ophthalmology 2019;():-

Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm
Filì M, Trocme E, Bergman L, See Tro, André H, Bartuma K, et al
The British journal of ophthalmology 2019;():-

Digital image analysis of Ki67 in hot spots is superior to alternative proliferation associated markers in breast cancer
Robertson S, Stalhammar G, Wedlund L, Gholizadeh S, Lippert M, Rantaleinen M, et al
CANCER RESEARCH 2018;78(4)

Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer
Stålhammar G, Robertson S, Wedlund L, Lippert M, Rantalainen M, Bergh J, et al
Histopathology 2018;72(6):974-989

Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
Ullah I, Karthik Gm, Alkodsi A, Kjällquist U, Stålhammar G, Lövrot J, et al
The Journal of clinical investigation 2018;128(4):1355-1370

Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs)
Kjällquist U, Erlandsson R, Tobin Np, Alkodsi A, Ullah I, Stålhammar G, et al
BMC cancer 2018;18(1):174-

Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer
Robertson S, Stålhammar G, Darai-ramqvist E, Rantalainen M, Tobin Np, Bergh J, et al
Journal of clinical pathology 2018;71(9):787-794

Tumour thickness, diameter, area or volume? The prognostic significance of conventional versus digital image analysis-based size estimation methods in uveal melanoma
Arnljots Ts, Al-sharbaty Z, Lardner E, All-eriksson C, Seregard S, Stålhammar G
Acta ophthalmologica 2018;96(5):510-518

Evolutionary analyses of matched primary and metastatic breast cancer reveal both linear and parallel progression with lack of axillary lymph node involvement
Ullah I, Muralidharan Kg, Alkodsi A, Kjallquist U, Stalhammar G, Lovrot J, et al
CANCER RESEARCH 2017;

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling
Karthik Gm, Rantalainen M, Stalhammar G, Lovrot J, Ullah I, Alkodsi A, et al
BMC CANCER 2017;:802-

Digital image analysis outperforms manual biomarker assessment in breast cancer
Stålhammar G, Fuentes Martinez N, Lippert M, Tobin Np, Mølholm I, Kis L, et al
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016;29(4):318-29

Digital image analysis outperforms manual scoring for breast cancer subclassification and prognostication
Stalhammar G, Rosin G, Kis L, Lippert M, Moelholm I, Grunkin M, et al
CANCER RESEARCH 2016;

Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms
Stålhammar G, Farrajota P, Olsson A, Silva C, Hartman J, Elmberger G
Annals of diagnostic pathology 2015;19(4):203-10

Response to correspondence on 'low concordance of biomarkers in histopathological and cytological material from breast cancer'
Stålhammar G, Hartman J
Histopathology 2015;66(5):756-8

Low concordance of biomarkers in histopathological and cytological material from breast cancer
Stålhammar G, Rosin G, Fredriksson I, Bergh J, Hartman J
Histopathology 2014;64(7):971-80

Sebaceous epithelial-myoepithelial carcinoma of the parotid gland: a case report of a new histologic variant
Stålhammar G, Elmberger G
Annals of diagnostic pathology 2014;18(4):248-52

Show all publications

Map

View map

Polhemsgatan 50
Stockholm

Presentations

Video presentation of Gustav Stålhammar